Sellas Life Sciences Reports Positive Results From Trial for Cancer Vaccine
By Kelly CloonanSellas Life Sciences Group said its immunotherapeutic cancer vaccine demonstrated a statistically significant and clinically meaningful improvement in overall survival in patients with acute myeloid leukemia in a Phase 3 trial.Sellas said Tuesday the vaccine, called galinpepimut-S…